Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013–15

Publisher： John Wiley & Sons Inc

E-ISSN： 1753-6405|42|1|62-68

ISSN： 1326-0200

Source： AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, Vol.42, Iss.1, 2018-02, pp. : 62-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tenofovir in the treatment of chronic hepatitis B

By Yu Derek   Heathcote Jenny  

Therapy, Vol. 8, Iss. 5, 2011-09 ,pp. : 527-544

Future Medicine

Access to resources Recommend Favorite

The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment

By  

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, Vol. 39, Iss. 3, 2015-06 ,pp. : 255-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

On‐treatment monitoring of chronic hepatitis B virus infection: An Asian–Pacific perspective

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 5, 2010-05 ,pp. : 852-857

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence of Hepatitis E Virus Antibodies in Patients with Chronic Hepatitis B and Chronic Hepatitis C

By  

Intervirology, Vol. 50, Iss. 4, 2007-06 ,pp. : 281-286

Karger

Access to resources Recommend Favorite

A review of entecavir in the treatment of chronic hepatitis B infection

By Rivkin Anastasia  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1845-1856

Informa Healthcare

Access to resources Recommend Favorite